Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals
about
Efavirenz and the CNS: what we already know and questions that need to be answeredAssociation between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1/CO11)EUROmediCAT signal detection: an evaluation of selected congenital anomaly-medication associationsDrug safety evaluation of oral tenofovir disoproxil fumarate-emtricitabine for pre-exposure prophylaxis for human immunodeficiency virus infection.Antiretroviral therapy, pregnancy, and birth defects: a discussion on the updated data.Pregnancy complications in HIV-positive women: 11-year data from the Frankfurt HIV Cohort.Medication use in pregnancy in relation to the risk of isolated clubfoot in offspringIncidence of pregnancy after initiation of antiretroviral therapy in South Africa: a retrospective clinical cohort analysis.Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infantsBirth defects in a cohort of infants born to HIV-infected women in Spain, 2000-2009.CLEFT PALATE IN HIV-EXPOSED NEWBORNS OF MOTHERS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY.First trimester exposure to antiretroviral therapy and risk of birth defectsSevere Infections in HIV-Exposed Uninfected Infants Born in a European CountryZidovudine use in pregnancy and congenital malformations.Prenatal ultrasound screening for fetal anomalies and outcomes in high-risk pregnancies due to maternal HIV infection: a retrospective study.Disclosing in utero HIV/ARV exposure to the HIV-exposed uninfected adolescent: is it necessary?Paternal involvement and fetal morbidity outcomes in HIV/AIDS: a population-based study.HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults.Tolerance of the newborn to antiretroviral drug exposure in utero.Efavirenz-based antiretroviral therapy versus nevirapine-including regimens for prevention of mother-to-child transmission of HIV option B plus in resource-limited settings: is there anything missing?Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis.Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.British HIV Association guidelines for the management of HIV infection in pregnant women 2012
P2860
Q28085028-04EE8FB4-6E29-4F6E-8D38-3FDE4B9B3DC1Q28538279-FA8EFF4D-9514-4A50-BA5A-0FA37BF29D9DQ28817912-19C5CADC-B465-4CEF-B8AE-7184A6EBDB35Q30249113-93383D3E-998A-40E9-A882-817A13CCDE5AQ30661395-4391EC83-CDE0-4A53-B9D5-F43C7EB04DA7Q30772144-2F74E408-B195-49E0-A90E-9273D4FC2A34Q34048103-EA5D3F5A-90CA-403E-8A1D-F059101EEE56Q34331885-B4427A0E-FB6D-48EF-829D-A922ABF9B1A3Q34860149-AF9B305D-C11D-4635-95EA-594DA20283DFQ34979228-88B7004D-467D-4975-BF8A-444EA96DEDB0Q35038144-B4C0EDA2-B759-41A1-A682-5F2B43F3C7C6Q35572618-E5B34BD8-B745-4110-B7BF-A1CF28081C9CQ35748668-DEC89C5A-4AA7-42A6-BEC1-8C55D4AFDD61Q36379162-E433E911-8351-4B4B-B522-38947AB365EBQ37243085-AE48B18A-5AFF-48F2-9315-D204169952A5Q37342120-6A5406B7-D9A8-4743-BF05-4D8EEF8F802BQ37540798-D97F97A2-C2E5-4C44-AAFB-5526E8361159Q38021848-AF49FFDE-55C8-4768-9983-54596FBDBC74Q38366365-B9132295-6A74-4D01-9049-D4D4D52EC89CQ38630880-DB9D3A75-D90D-4750-BD3A-FBA04551EBA6Q38861593-4A0FF462-495F-4682-8A0E-77FFAC9CCD7CQ38909409-873BAEF6-8E83-4D6F-905B-3751BF2CB7B2Q42260917-1BA26954-AB80-4231-AD33-B3C7929F2C59Q57076282-E81D2DC9-5ACA-4083-B627-7C9CC0416022
P2860
Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals
@ast
Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals
@en
type
label
Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals
@ast
Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals
@en
prefLabel
Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals
@ast
Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals
@en
P2093
P2860
P1476
Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals
@en
P2093
Daniel G Muenz
Daniel H Conway
David E Shapiro
Gwendolyn B Scott
Hans M L Spiegel
Jeffrey T Talbot
Jennifer S Read
Katherine M Knapp
Susan B Brogly
P2860
P304
P356
10.1097/INF.0B013E318235C7AA
P577
2012-02-01T00:00:00Z